Advancing Type 2 Diabetes Care with Omnipod® 5

Omnipod®

V. Shah, D. Kruger, T. Ly

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Omnipod®

J. Okemah

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Omnipod®

M. Heyman

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Omnipod®

F. Pasquel

Tirzepatide Updates

Diana Isaacs

Weightloss in Menopause

Susan Brian

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Could It Be Cushing’s? Rethinking Diabetes Management with the CATAL…

Robert Busch

Optimizing Omnipod 5 Therapy: Case Studies - TCOYD

Omnipod®

S. Edelman, J. Pettus

Diabetic Peripheral Neuropathy: A Review of Clinical Practice Guidel…

Michigan Medicine - Podiatry

G. Rothenberg

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

Wegovy 2024 Updates

Susan Brian

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

Krista Varady

Perioperative Management of Anticoagulants: Podiatry Education Series

Michigan Medicine - Podiatry

M. Munson